2023-05-04 02:47:52
AstraZeneca Korea announced on the 4th that it had appointed Lim Jae-yoon (Country Medical Director) to oversee the medical department.
Lim Jae-yoon, Executive Director of AstraZeneca Korea Medical Department, joined AstraZeneca Korea Medical Department as Oncology therapeutic area Lead in 2019 and contributed to solidifying AstraZeneca’s scientific leadership in the process of clinical trials, launch, reimbursement, and partnerships of anti-cancer products did.
In particular, in the process of rapidly expanding the anticancer drug portfolio, it has proven its leadership within the organization in the process of launching major anticancer drug products such as Tagrisso, Impinzi, Enhertu, Lynparza, and Cocellugo, expanding indications, and providing reimbursement.
Prior to joining AstraZeneca Korea, Lim led the clinical development of anticancer drugs at Samsung Bioepis. Prior to that, he served as a postdoctoral researcher at MD Anderson Cancer Center Research Institute at the University of Texas, USA, and as a professor at Yonsei University College of Medicine for regarding 8 years. accumulated experience in
Executive Director Lim obtained a medical oncology specialist from Yonsei University College of Medicine and has been active in domestic and international academic activities as a regular member of the Korean Cancer Society, the American Society of Oncology (ASCO), and the European Society of Oncology (ESMO).
1683170460
#AstraZeneca #Korea #appoints #executive #director #Lim #Jaeyoon #medical #department
